Delta 9 Cannabis Inc. announced that it has signed a Master License Agreement with NanoSphere Health Sciences, LLC and its NanoSphere Cannabis International Inc. The Agreement provides Delta 9 with an exclusive license in Canada to manufacture and sell products made with Nanosphere's patented technology for the delivery of cannabinoids via nanoparticle technology. The two companies are already working on the first product for Canada; an intraoral cannabis oil containing cannabinoid nanoparticles, that is being produced over the next month for an upcoming inspection for final approval by Health Canada.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.01 CAD | 0.00% | 0.00% | -60.00% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-60.00% | 2.58M | |
+61.53% | 856B | |
+38.95% | 631B | |
-3.66% | 359B | |
+15.06% | 325B | |
+9.18% | 297B | |
+5.89% | 234B | |
+16.53% | 226B | |
+15.67% | 177B | |
+2.47% | 165B |
- Stock Market
- Equities
- DN Stock
- News Delta 9 Cannabis Inc.
- Delta 9 Cannabis Inc. Signs Master License Agreement with NanoSphere Health Sciences and Nanosphere Cannabis International